Topic prioritisation
Showing 1 to 8 of 8
| Title | Prioritisation programme | Decision | Decision date |
|---|---|---|---|
| Semaglutide for treating type 2 diabetes in people 10 to 17 years [TSID12249] | None selected | Not selected | |
| Dasiglucagon for treating severe hypoglycaemia caused by type 1 diabetes in people under 6 years [TSID12255] | None selected | Not selected | |
| Orforglipron for treating type 2 diabetes [TSID12130] | None selected | Not selected | |
| Basal insulin icodec–semaglutide for treating type 2 diabetes inadequately controlled with daily basal insulin [TSID11940] | None selected | Not selected | |
| PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes, (MT740) | None selected | Not selected | |
| Semaglutide for treating type 2 diabetes and associated peripheral arterial disease [TSID11791] | None selected | Not selected | |
| Dulaglutide for treating type 2 diabetes in children and young people [TSID10660] | None selected | Not selected | |
| d-NAV for optimization of personal insulin management in adults with type 2 diabetes (MT696) | None selected | Not selected |